TFA Therapeutics annual gross profit
2021
2022
2023
2024
2025
TFA Therapeutics Gross Profit Growth & History (RAJAF)
TFA Therapeutics's gross profit was $760,741 for fiscal 2025.
View full TFA Therapeutics company overviewTFA Therapeutics annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $760,741 | −$145,739 | −16.08% |
| 2024 | 2024-12-31 | $906,480 | $140,093 | +18.28% |
| 2023 | 2023-12-31 | $766,387 | $726,829 | +1837.38% |
| 2022 | 2022-12-31 | $39,558 | $215,770 | — |
| 2021 | 2021-12-31 | −$176,212 | — | — |
TFA Therapeutics gross profit trends
Between the periods ended 2021-12-31 and 2025-12-31, TFA Therapeutics's gross profit increased from −$176,212 to $760,741, a change of $936,953.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TFA Therapeutics source filings ↗